Admissions alert

London School of Economics (LSE) led postgraduate programmes in India

London School of Economics (LSE) led postgraduate programmes in India

Applications to get admission into the postgraduate programmes of the Indian School of Business & Finance (ISBF) for session 2021 are closing soon. The one-year programmes are academically directed by London School of Economics and are validated by the University of London.

ISBF is one of the top five Teaching Institutions of The London School of Economics and Political Science (LSE), included in the top 10 globally for economics, management and finance (QS Rankings, 2020). All programmes - undergraduate and postgraduate - are taught with academic direction from LSE, and the degree/diploma is awarded by the University of London.

ISBF has 100 seats for the 2021 intake across four graduate diploma programmes, namely,

▪       Graduate Diploma in Economics

▪       Graduate Diploma in Finance

▪       Graduate Diploma in Management

▪       Graduate Diploma in Data Science

 Admission details: ISBF follows a rounds-based rolling admissions policy, which means that other things equal, applicants of earlier rounds have a higher likelihood of being accepted into the programme of their choice. It also means that applications will be closed as soon as all seats are filled.

Every admission round comprises of three steps:

Step 1: Filling the Application Form

Step 2: ISBF Graduate Diploma Entrance Test (iGDET)

Step 3: Appearing for the Personal Interview (PI)

Eligibility for applying: Candidates who have successfully completed or are in the final year of full-time undergraduate degree programme, are eligible to apply for the postgraduate programmes at ISBF.

Candidates applying for the Graduate Diploma in Economics or Data Science must have studied Mathematics at least up to Class XII.

Students can submit their applications at https://www.isbf.edu.in/postgraduate-courses/pg-admissions/

Top Stories

Covaxin shows 77.8% efficacy in phase-3 trials

Covaxin shows 77.8% efficacy in phase-3 trials

Only one India-made vaccine, Covishield, is on WHO list, cur...

Prepare for 3rd wave, vaccinate on war footing: Rahul

Prepare for 3rd wave, vaccinate on war footing: Rahul

Releases white paper on Covid ‘mismanagement’ | Smriti says ...

Cities

View All